Alpharma Generic Neurontin Approval Precedes FDA Reinspection

Approval of Alpharma's ANDA for a generic version of Pfizer's Neurontin (gabapentin) comes just ahead of FDA's expected reinspection of the Elizabeth, N.J. facility where gabapentin will be manufactured

More from Archive

More from Pink Sheet